Related Experiment Video
Updated: Apr 15, 2026
![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)
Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test
Published on: March 23, 2013
Diabetic Gastroparesis in Evolution
Audrey Eubanks1, Deborah A Jehu1, Chuma Obineme2
1School of Public Health, Augusta University, Augusta, GA.
None:
Diabetic gastroparesis (DGp) is a chronic and often debilitating complication of diabetes mellitus, characterized by delayed gastric emptying in the absence of mechanical obstruction. Over the past 6 decades, our understanding of DGp has evolved considerably. Clinically, DGp presents with symptoms such as nausea, vomiting, early satiety, bloating, and abdominal pain, which are not always proportional to the degree of gastric emptying delay, underscoring the nature of the disorder. To prepare this review, we conducted a targeted narrative synthesis of the literature, performing structured searches of PubMed, Embase, and Scopus for English-language articles published between 2013 and 2025. Articles were screened for relevance and thematically organized into domains including diagnostics, therapeutics, and emerging interventions. This review provides a comprehensive, chronological account of the evolving landscape of DGp, beginning with early clinical recognition, creation of validated characterization, development of diagnostic modalities with standardized protocols, such as gastric emptying scintigraphy, wireless motility capsule, and emerging modalities such as gas-sensing capsule, body surface gastric mapping, and dynamic gastric magnetic resonance imaging. Treatments for DGp are similarly evolving from traditional promotility dopamine receptor antagonists to nonpharmacologic strategies targeting the gut-brain axis and pylorus-directed procedures. By integrating historical perspectives with contemporary advances, this review provides context for future research directions aimed at improving patient outcomes in this challenging disorder.
More Related Videos
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...